Skip to main content
Log in

Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia

  • Full Papers
  • Published:
Journal of Neural Transmission / General Section JNT Aims and scope Submit manuscript

Summary

A unique model of DA system regulation is presented, in which tonic steady-state DA levels in the ECF act to down-regulate the response of the system to pulsatile DA released by DA cell action potential generation. This type of regulation is similar in many respects to the phenomenon proposed to mediate the action of norepinephrine on target neurons; i.e., an increase in the “signal-to-noise” ratio as measured by postsynaptic cell firing (Freedman et al., 1977; Woodward et al., 1979). However, in this model the signal and the noise are neurochemical rather than electrophysiological. Furthermore, the “noise” (tonic DA in the ECF) actually down-regulates the “signal” (phasic DA release) directly, and thereby provides a “signal” of its own that affects the system over a longer time-course. Therefore, the difference between signal and noise may also depend on the time frame under which such determinations are made.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Adler M (1961) Changes in sensitivity to amphetamine in rats with chronic brain lesions. J Pharmacol Exp Ther 134: 214–224

    Google Scholar 

  • Alpert M, Friedhoff AJ, Marcos LR, Diamond F (1978) Paradoxical reactions to L-dopa in schizophrenic patients. Am J Psychiatry 135: 1327–1332

    Google Scholar 

  • Andén N-E, Fuxe K, Hamberger B, Hökfelt T (1966) A quantitative study of the nigroneostriatal dopamine neuron system in the rat. Acta Physiol Scand 67: 306–312

    Google Scholar 

  • Angrist BM, Shopsin B, Gershon S (1971) The comparative psychotomimetic effects of stereoisomers of amphetamine. Nature (London) 234: 152–153

    Google Scholar 

  • Angrist BM, Rotrosen J, Gershon S (1980) Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia. Psychopharmacology 72: 17–19

    Google Scholar 

  • Baldessarini RJ (1985) Drugs and the treatment of psychiatric disorders. In: Gilman AG, Goodman LS, Rall TW, Murad F (eds) The pharmacological basis of therapeutics, 7th ed. MacMillan, New York, pp 387–445

    Google Scholar 

  • Beninger RJ (1983) The role of dopamine in locomotor activity and learning. Brain Res Rev 6: 173–196

    Google Scholar 

  • Benveniste H (1991) Microdialysis — theory and application. In: Gardner E, Nicholson C (eds) Measuring the chemical microenvironment. Society for Neuroscience, Washington DC, pp 54–64

    Google Scholar 

  • Benveniste H, Hüttemeier PC (1990) Microdialysis — theory and application. Prog Neurobiol 35: 195–215

    Google Scholar 

  • Bindra D (1978) How adaptive behavior is produced — perceptual-motivational alternative to response reinforcement. Behav Brain Sci 1: 41–52

    Google Scholar 

  • Blaha CD, Lane RF (1987) Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbensin vivo. Neurosci Lett 78: 199–204

    Google Scholar 

  • Bogerts B (1985) Evidence for structural changes in the limbic system in schizophrenia. In: Shagass C, Josiassen RC, Bridger WH, Weiss KJ, Stoff D, Simpson GM (eds) Biological psychiatry. Elsevier, New York, pp 1015–1020

    Google Scholar 

  • Bogerts B, Meertz E, Schonfeld-Bausch R (1985) Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage. Arch Gen Psychiatry 42: 784–791

    Google Scholar 

  • Bouyer JJ, Park DH, Joh TH, Pickel VM (1984) Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum. Brain Res 302: 267–276

    Google Scholar 

  • Bunney BS, Aghajanian GK (1976) The precise localization of nigral afferents in the rat as determined by retrograde tracing techniques. Brain Res 117: 423–435

    Google Scholar 

  • Bunney BS, Grace AA (1978) Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. Life Sci 23: 1715–1728

    Google Scholar 

  • Bunney BS, Grace AA (1979) Effects of chronic haloperidol treatment on nigral dopaminergic cell activity. In: Usdin E, Kopin IJ, Barchas J (eds) Catecholamines: basic and clinical frontiers. Pergamon Press, New York, pp 666–668

    Google Scholar 

  • Bunney BS, Walters JR, Roth RH, Aghajanian GK (1973) Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 185: 560–571

    Google Scholar 

  • Carlsson A, Lindqvist M (1963) Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 20: 140–144

    Google Scholar 

  • Carlsson A, Lindqvist M, Magnusson T, Waldeck B (1958) On the presence of 3-hydroxytyramine in brain. Science 127: 471

    Google Scholar 

  • Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia — implications for schizophrenia and Parkinson's disease. Trends Neurosci 13: 272–276

    Google Scholar 

  • Chen J, Paredes W, Gardner EL (1991) Chronic treatment with clozapine selectively decreases basal dopamine release in nucleus accumbens but not in caudate-putamen as measured by in vivo brain microdialysis: further evidence for depolarization block. Neurosci Lett 122: 127–131

    Google Scholar 

  • Chesselet MF, Chéramy A, Romo R, Desban M, Glowinski J (1983) GABA in the thalamic motor nuclei modulates dopamine release from two dopaminergic nigrostriatal pathways in the cat. Exp Brain Res 51: 275–282

    Google Scholar 

  • Chiodo LA, Bunney BS (1983) Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A 9 and A 10 midbrain dopaminergic neurons. J Neurosci 3: 1607–1619

    Google Scholar 

  • Chiodo LA, Bunney BS (1985) Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons. J Neurosci 5: 2539–2544

    Google Scholar 

  • Chiodo LA, Bunney BS (1987) Population response of midbrain dopaminergic neurons to neuroleptics: further studies on time course and nondopaminergic neuronal influences. J Neurosci 7: 629–633

    Google Scholar 

  • Church WH, Justice JB, Neil DB (1987) Detecting behaviorally relevant changes in extracellular dopamine with microdialysis. Brain Res 412: 397–399

    Google Scholar 

  • Colle LM, Wise RA (1988) Effects of nucleus accumbens amphetamine on lateral hypothalamic brain stimulation reward. Brain Res 459: 361–368

    Google Scholar 

  • Connell PH (1958) Amphetamine psychosis. Chapman and Hall, London

    Google Scholar 

  • Conrad AJ, Abebe T, Austin R, Forsythe S, Scheibel AB (1991) Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Arch Gen Psychiatry 48: 413–417

    Google Scholar 

  • Deutch AY, Roth RH (1988) Alterations in dopamine synthesis by chronic neuroleptic administration: a possible biochemical correlate of depolarization inactivation. Soc Neurosci Abstr 14: 27

    Google Scholar 

  • Doherty MD, Gratton A (1991) Behavioral evidence of depolarization block of mesencephalic dopamine neurons by acute haloperidol in partially 6-hydroxydopamine lesioned rats. Behav Neurosci 105: 579–587

    Google Scholar 

  • Doucet G, Descarries L, Garcia S (1986) Quantification of the dopamine innervation in adult rat neostriatum. Neuroscience 19: 427–445

    Google Scholar 

  • Ewing AG, Wightman RM (1984) Monitoring the stimulated release of dopamine within vivo voltammetry. II. Clearance of released dopamine from extracellular fluid. J Neurochem 43: 570–577

    Google Scholar 

  • Fabre M, Rolls ET, Ashton JP, Williams G (1983) Activity of neurons in the ventral tegmental region of the behaving monkey. Behav Brain Res 9: 213–235

    Google Scholar 

  • Farnebo L-O, Hamberger B (1971) Drug-induced changes in the release of3 H-monoamines from field-stimulated rat brain slices. Acta Physiol Scand [Suppl] 371: 35–44

    Google Scholar 

  • Fibiger HC, LePiane FG, Jakubovic A, Phillips AG (1987) The role of dopamine in intracranial self-stimulation of the ventral tegmental area. J Neurosci 7: 3888–3896

    Google Scholar 

  • Finlay JM, Jakubovic A, Fu DS, Fibiger HC (1987) Tolerance to haloperidol-induced increases in dopamine and metabolites: fact or artifact? Eur J Pharmacol 137: 117–121

    Google Scholar 

  • Freedman R, Hoffer BJ, Woodward DJ, Puro D (1977) Interaction of norepinephrine with cerebellar activity evoked by mossy and climbing fibers. Exp Neurol 55: 269–288

    Google Scholar 

  • Freund TF, Powell JF, Smith AD (1984) Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons with particular reference to dendritic spines. Neuroscience 13: 1189–1215

    Google Scholar 

  • Friedhoff AJ, Miller JC (1983) Clinical implications of receptor sensitivity modification. Annu Rev Neurosci 6: 121–148

    Google Scholar 

  • Gerfen CR (1984) The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems. Nature 311: 461–464

    Google Scholar 

  • Gerlach J, Luhdorf K (1975) The effect of L-DOPA on young patients with simple schizophrenia treated with neuroleptic drugs: a double-blind crossover trial with madopar and placebo. Psychopharmacology 44: 105–110

    Google Scholar 

  • Glowinski J, Chéramy A, Romo R, Barbeito L (1988) Presynaptic regulation of dopaminergic transmission in the striatum. Cell Mol Neurobiol 8: 7–17

    Google Scholar 

  • Goldstein JM, Litwin LC (1988) Spontaneous activity of A 9 and A 10 dopamine neurons after acute and chronic administration of the selective dopamine D-1 receptor antagonist SCH 23390. Eur J Pharmacol 155: 175–180

    Google Scholar 

  • Goldstein JM, Litwin LC, Sutton EB, Malick JB (1989) Effects of ICI 169,369, a selective serotonin2 antagonist, in electrophysiological tests predictive of antipsychotic activity. J Pharmacol Exp Ther 249: 673–680

    Google Scholar 

  • Gonon FG (1988) Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience 24: 19–28

    Google Scholar 

  • Grace AA (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41: 1–24

    Google Scholar 

  • Grace AA, Bunney BS (1980) Effects of baclofen on nigral dopaminergic cell activity following acute and chronic haloperidol treatment. Brain Res Bull 5 [Suppl 2]: 537–543

    Google Scholar 

  • Grace AA, Bunney BS (1983) Intracellular and extracellular electrophysiology of nigral dopamine neurons. I. Identification and characterization. Neuroscience 10: 301–315

    Google Scholar 

  • Grace AA, Bunney BS (1984 a) The control of firing pattern in nigral dopamine neurons: single spike firing. J Neurosci 4: 2866–2876

    Google Scholar 

  • Grace AA, Bunney BS (1984 b) The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 4: 2877–2890

    Google Scholar 

  • Grace AA, Bunney BS (1985 a) Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity. Brain Res 333: 271–284

    Google Scholar 

  • Grace AA, Bunney BS (1985 b) Low doses of apomorphine elicit two opposing influences on dopamine cell electrophysiology. Brain Res 333: 285–298

    Google Scholar 

  • Grace AA, Bunney BS (1986) Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording. J Pharmacol Exp Ther 238: 1092–1100

    Google Scholar 

  • Grace AA, Onn S-P (1989) Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recordedin vitro. J Neurosci 9: 3463–3481

    Google Scholar 

  • Gratton A, Hoffer BJ, Gerhardt GA (1988) Effects of electrical stimulation of brain reward sites on release of dopamine in rat: an in vivo electrochemical study. Brain Res Bull 21: 319–324

    Google Scholar 

  • Graybiel AM, Ragsdale CW (1983) Biochemical anatomy of the striatum. In: Emson PC (ed) Chemical neuroanatomy. Raven Press, New York, pp 427–504

    Google Scholar 

  • Guyenet PG, Aghajanian GK (1978) Antidromic identification of dopaminergic and other output neurons of the rat substantia nigra. Brain Res 150: 69–84

    Google Scholar 

  • Herrling PL (1985) Pharmacology of the corticocaudate excitatory postsynaptic potential in the cat: evidence for its mediation by quisqualate or kainate receptors. Neuroscience 14: 417–426

    Google Scholar 

  • Hollerman JR, Grace AA (1989) Acute haloperidol administration induces depolarization block of nigral dopamine neurons in rats after partial dopamine lesions. Neurosci Lett 96: 82–88

    Google Scholar 

  • Hollerman JR, Abercrombie ED, Grace AA (1992) Electrophysiological, biochemical, and behavioral studies of acute haloperidol-induced depolarization block of nigral dopamine neurons. Neuroscience 47: 589–601

    Google Scholar 

  • Hornykiewicz O (1963) Die topische Lokalisation und das Verhalten von Noradrenalin und Dopamin (3-hydroxytyramin) in der Substantia nigra des normalen und Parkinsonkranken Menschen. Wien Klin Wochenschr 75: 309–355

    Google Scholar 

  • Ichikawa J, Meltzer HY (1991) Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens. J Pharmacol Exp Ther 256: 348–357

    Google Scholar 

  • Imperato I, DiChiara G (1985) Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis. J Neurosci 5: 297–306

    Google Scholar 

  • Ingvar DH, Franzen G (1974) Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr Scand 50: 425–462

    Google Scholar 

  • Invernizzi R, Morali F, Pozzi L, Samanin R (1990) Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats. Br J Pharmacol 100: 744–748

    Google Scholar 

  • Iversen SD (1971) The effect of surgical lesions to frontal cortex and substantia nigra on amphetamine responses in rats. Brain Res 31: 295–311

    Google Scholar 

  • Jiang LH, Tsai M, Wang RY (1988) Chronic treatment with high doses of haloperidol fails to decrease the time course for the development of depolarization inactivation of midbrain dopamine neurons. Life Sci 43: 75–81

    Google Scholar 

  • Johnstone E, Crow TJ, Frith CD, Carney MWP, Price JS (1978) Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet i: 848–851

    Google Scholar 

  • Kabzinski AM, Szewczak MR, Cornfeldt ML, Fielding S (1987) Differential effects of dopamine agonists and antagonists on the spontaneous electrical activity of A 9 and A 10 dopamine neurons. Soc Neurosci Abstr 13: 908

    Google Scholar 

  • Kaplan HI, Sadock BJ (1985) Comprehensive textbook of psychiatry, 4th ed. Williams and Wilkins, Baltimore

    Google Scholar 

  • Karoum F, Karson CN, Bigelow LB, Lawson WB, Wyatt RJ (1987) Preliminary evidence of reduced combined output of dopamine and its metabolites in chronic schizophrenia. Arch Gen Psychiatry 44: 604–607

    Google Scholar 

  • Kebabian JW, Calne R (1979) Multiple receptors for dopamine. Nature 277: 93–96

    Google Scholar 

  • Keefe KA, Stricker EM, Zigmond MJ, Abercrombie ED (1990) Environmental stress increases extracellular dopamine in striatum of 6-hydroxydopamine-treated rats: in vivo microdialysis studies. Brain Res 527: 350–353

    Google Scholar 

  • Keller RW, Duhr WG, Wightman RM, Zigmond MJ (1988) The effects of L-DOPA on in vivo dopamine release from nigrostriatal bundle neurons. Brain Res 447: 191–194

    Google Scholar 

  • Kiaytkin EA (1988) Functional properties of presumed dopamine-containing and other ventral tegmental area neurons in conscious rats. Int J Neurosci 42: 21–43

    Google Scholar 

  • Korf J, Venema K (1985) Amino acids in rat striatal dialysates: methodological aspects and changes after electroconvulsive shock. J Neurochem 45: 1341–1348

    Google Scholar 

  • Kuhr WG, Ewing AG, Caudill WL, Wightman RM (1984) Monitoring the stimulated release of dopamine within vivo voltammetry. I. Characterization of the response observed in the caudate nucleus of the rat. J Neurochem 43: 560–569

    Google Scholar 

  • Kuhr WG, Wightman RM (1986) Real-time measurement of dopamine release in rat brain. Brain Res 381: 168–171

    Google Scholar 

  • Lane RF, Blaha CD (1987) Chronic haloperidol decreases dopamine release in striatum and nucleus accumbensin vivo: depolarization block as a possible mechanism of action. Brain Res Bull 18: 135–138

    Google Scholar 

  • Lehman J, Langer SZ (1983) The striatal cholinergic interneuron: synaptic target of dopaminergic terminals? Neuroscience 10: 1105–1120

    Google Scholar 

  • Lehmann J, Smith RV, Langer SZ (1983) Stereoisomers of apomorphine differ in affinity and intrinsic activity at presynaptic dopamine receptors modulating [3 H] dopamine and [3 H] acetylcholine release in slices of cat caudate. Eur J Pharmacol 88: 81–88

    Google Scholar 

  • Lindstrom LH (1985) Low HVA and normal 5-HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: correlations to symptomatology and family history. Psychiatry Res 14: 265–273

    Google Scholar 

  • Lynch GS, Ballantine P, Campbell BA (1969) Potentiation of behavioral arousal after cortical damage and subsequent recovery. Exp Neurol 23: 195–206

    Google Scholar 

  • May LJ, Kuhr WG, Wightman RM (1988) Differentiation of dopamine overflow and uptake processes in the extracellular fluid of the rat caudate nucleus with fast-scan in vivo voltammetry. J Neurochem 51: 1060–1069

    Google Scholar 

  • McGeorge AJ, Faull RLM (1989) The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 29: 503–537

    Google Scholar 

  • Meltzer HY (1985) Dopamine and negative symptoms in schizophrenics: critique of the type I-type II hypothesis. In: Alpert M (ed) Controversies in schizophrenia: changes and constancies. Guilford Press, New York, pp 110–136

    Google Scholar 

  • Meltzer HY, Sommers AA, Luchins DJ (1986) The effects of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia. J Clin Pharmacol 6: 329–338

    Google Scholar 

  • Meltzer LT, Christoffersen CL, Heffner TG, Freeman AS, Chiodo LA (1989) CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity. J Pharmacol Exp Ther 251: 123–130

    Google Scholar 

  • Miller JD, Sanghera MK, German DC (1981) Mesencephalic dopaminergic unit activity in the behaviorally conditioned rat. Life Sci 29: 1255–1263

    Google Scholar 

  • Mishra RK, Marshall AM, Varmuza SL (1980) Supersensitivity in rat caudate nucleus: effects of 6-hydroxydopamine on the time course of dopamine receptor and cyclic AMP changes. Brain Res 200: 47–57

    Google Scholar 

  • Mitchell PR, Doggett NS (1980) Modulation of striatal3 H-glutamic acid release by dopaminergic drugs. Life Sci 26: 2073–2081

    Google Scholar 

  • Mogenson GJ, Jones DL, Yim CY (1980) From motivation to action: functional interface between limbic system and the motor system. Prog Neurobiol 14: 69–97

    Google Scholar 

  • Moghaddam B, Gruen RJ (1991) Do endogenous excitatory amino acids influence striatal dopamine release? Brain Res 544: 329–330

    Google Scholar 

  • Nakahara D, Ozaki N, Kapoor V, Nagatsu T (1989) The effect of uptake inhibition on dopamine release from the nucleus accumbens of rats during self- or forced stimulation of the medial forebrain bundle. A microdialysis study. Neurosci Lett 104: 136–140

    Google Scholar 

  • Nieoullon A, Chéramy A, Glowinski J (1978) Release of dopamine evoked by electrical stimulation of the motor and visual areas of the cerebral cortex in both caudate nuclei and in the substantia nigra in the cat. Brain Res 145: 69–83

    Google Scholar 

  • O'Donnell P, Grace AA (1991) Dye-coupling is differentially affected by apomorphine in accumbens core and shell neurons. Soc Neurosci Abstr 17: 456

    Google Scholar 

  • Olds ME (1990) Enhanced dopamine receptor activation in accumbens and frontal cortex has opposite effects on medial forebrain bundle self-stimulation. Neuroscience 35: 313–325

    Google Scholar 

  • Onn SP, Berger TW, Grace AA (1991) Dye-coupling in type I and type II striatal neurons: alteration by apomorphine and localization to the patch/matrix. Soc Neurosci Abstr 17: 850

    Google Scholar 

  • Peroutka SJ, Snyder SH (1980) Relationship of neuroleptic drug effects at brain dopamine, serotonin, α-adrenergic, and histamine receptors to clinical potency. Am J Psychiatry 137: 1518–1522

    Google Scholar 

  • Pettegrew JW, Keshavan M, Panchalingam K (1989)31 P NMR studies in schizophrenia. Biol Psychiatry 25: 15 A

    Google Scholar 

  • Pettegrew JW, Keshavan MS, Panchalingam K, Strychor S, Kaplan DB, Tretta M, Allen M (1991) Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. Arch Gen Psychiatry 48: 563–568

    Google Scholar 

  • Pickar D, Labarca R, Linnoila M, Roy A, Hommer D, Everett D, Paul SM (1984) Neuroleptic-induced decrease in plasma HVA and antipsychotic activity in schizophrenic patients. Science (NY) 225: 954–957

    Google Scholar 

  • Pickar D, Labarca R, Doran AR, Wolkowitz OM, Roy A, Breier A, Linnoila M, Paul SM (1986) Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Arch Gen Psychiatry 43: 669–676

    Google Scholar 

  • Pickel VM, Beckley SC, Joh TH, Reis DJ (1981) Ultrastructural immunocytochemical localization of tyrosine hydroxylase in the neostriatum. Brain Res 225: 373–385

    Google Scholar 

  • Powell EW, Lehman RB (1976) Connections of the nucleus accumbens. Brain Res 105: 389–403

    Google Scholar 

  • Reimann W, Zumstein A, Starke K (1982) γ-Aminobutyric acid can both inhibit and facilitate dopamine release in the caudate nucleus of the rabbit. J Neurochem 39: 961–969

    Google Scholar 

  • Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T, Casella V, Fowler J, Hoffman E, Alavi A, Som P, Sokoloff L (1979) The (18 F) fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 44: 127–137

    Google Scholar 

  • Richfield EK, Penney JB, Young AB (1989) Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system. Neuroscience 30: 767–777

    Google Scholar 

  • Roberts GW, Bruton CJ (1990) Notes from the graveyard: neuropathology and schizophrenia. Neuropathol Appl Neurobiol 16: 3–16

    Google Scholar 

  • Robinson TE, Whishaw IQ (1988) Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res 450: 209–224

    Google Scholar 

  • Rompré P-P, Wise RA (1989) Behavioral evidence for midbrain dopamine neuron depolarization block. Brain Res 477: 152–156

    Google Scholar 

  • Rowlands GJ, Roberts PJ (1980) Activation of dopamine receptors inhibits calcium-dependent glutamate release from cortico-striatal terminalsin vitro. Eur J Pharmacol 62: 241–242

    Google Scholar 

  • Sah P, Hestrin S, Nicoll RA (1989) Tonic activation of NMDA receptors by ambient glutamate enhances excitability of neurons. Science (NY) 246: 815–818

    Google Scholar 

  • Sands SB, Barish ME (1989) A quantitative description of excitatory amino acid neurotransmitter responses on cultured embryonicXenopus spinal neurons. Brain Res 502: 375–386

    Google Scholar 

  • Scewczak MR, Dunn RW, Corbett R, Geyer HM, Rush DK, Wilker JC, Strupczewski JT, Helsely GC, Cornfeldt ML (1990) Thein vivo pharmacology of the novel antipsychotic HP 873. Soc Neurosci Abstr 16: 249

    Google Scholar 

  • Schultz W (1986) Responses of midbrain dopamine neurons to behavioral trigger stimuli in the monkey. J Neurophysiol 56: 1439–1461

    Google Scholar 

  • Schultz W, Romo R (1990) Dopamine neurons of the monkey midbrain: contingencies of responses to stimuli eliciting immediate behavioral reactions. J Neurophysiol 63: 607–624

    Google Scholar 

  • Sedvall G, Farde L, Persson A, Weisel FA (1986) Imaging of neurotransmitter receptors in the living human brain. Arch Gen Psychiatry 43: 995–1006

    Google Scholar 

  • Serrano A, D'Angio M, Scatton B (1989) NMDA antagonists block restraint-induced increase in extracellular DOPAC in rat nucleus accumbens. Eur J Pharmacol 162: 157–166

    Google Scholar 

  • Sesack SR, Pickel VM (1989) Ultrastructural basis for modulatory interactions between hippocampal and dopaminergic afferents to the rat nucleus accumbens. Soc Neurosci Abstr 15: 1229

    Google Scholar 

  • Sharp T, Zetterström T, Ungerstedt U (1986) An in vivo study of dopamine release and metabolism in rat brain regions using intracerebral dialysis. J Neurochem 47: 113–122

    Google Scholar 

  • Shelton RC, Karson CN, Doran AR, Pickar D, Bigelow LB, Weinberger DR (1988) Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defect. Am J Psychiatry 145: 154–163

    Google Scholar 

  • Skarsfeldt T (1988) Differential effects after repeated treatment with haloperidol, clozapine, thioridazine, and tefludazine on SNC and VTA dopamine neurons in rats. Life Sci 42: 1037–1044

    Google Scholar 

  • Skarsfeldt T, Perregaard J (1990) Sertindole, a new neuroleptic with extreme selectivity on A 10 versus A 9 dopamine neurons in the rat. Eur J Pharmacol 182: 613–614

    Google Scholar 

  • Snyder SH (1972) Catecholamines in the brain are mediators of amphetamine psychosis. Arch Gen Psychiatry 27: 169–179

    Google Scholar 

  • Sorensen SM, Humphreys TM, Palfreyman MG (1989) Effect of acute and chronic MDL 7314EF, a 5-HT3 receptor antagonist, on A 9 and A 10 dopamine neurons. Eur J Pharmacol 163: 115–118

    Google Scholar 

  • Stoof JC, Deboer TH, Sminia P, Mulder AH (1982) Stimulation of D-2 dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of GABA, glutamate or serotonin. Eur J Pharmacol 84: 211–214

    Google Scholar 

  • Tamminga CA, Schaffer MH, Smith RC, Davis JM (1978) Schizophrenic symptoms improve with apomorphine. Science 200: 567–568

    Google Scholar 

  • Tamminga CA, Kaneda H, Buchanan R, Kirkpatrick B, Thaker GK, Yablinski MB, Holcomb HH (1991) The limbic system in schizophrenia. Pharmacologic and metabolic evidence. In: Tamminga CA, Schulz SC (eds) Advances in neuropsychiatry and psychopharmacology, vol 1. Schizophrenia research. Raven Press, New York, pp 99–109

    Google Scholar 

  • Totterdell S, Smith AD (1989) Convergence of hippocampal and dopaminergic input onto identified neurons in the nucleus accumbens of the rat. J Chem Neuroanat 2: 285–298

    Google Scholar 

  • Van Kammen DP, Mann LS, Sternberg DE, Scheinin M, Ninan PT, Marder SR, Van Kammen WB, Reider RO, Linnoila M (1983) Dopamine-β-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenic with brain atrophy. Science 220: 974–977

    Google Scholar 

  • Van Kammen DP, Van Kammen WB, Mann LS, Seppala T, Linnoila M (1986) Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy. Arch Gen Psychiatry 43: 978–983

    Google Scholar 

  • Van Rossum JM (1966) The significance of dopamine-receptor blockade for the actions of neuroleptic drugs. Arch Int Pharmacodyn Thér 160: 492–494

    Google Scholar 

  • Weinberger DR, Berman KF, Zec RF (1986) Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. Arch Gen Psychiatry 43: 114–124

    Google Scholar 

  • White FJ, Wang RY (1983 a) Comparison of the effects of chronic haloperidol treatment on A 9 and A 10 dopamine neurons in the rat. Life Sci 32: 983–993

    Google Scholar 

  • White FJ, Wang RY (1983 b) Differential effects of classical and atypical antipsychotic drugs on A 9 and A 10 dopamine neurons. Science (NY) 221: 1054–1057

    Google Scholar 

  • Williamson P, Drost D, Stanley J, Carr T, Morrison S, Merskey H (1991) Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls. Arch Gen Psychiatry 48: 578

    Google Scholar 

  • Woodward DJ, Moises HC, Waterhouse BD, Hoffer BJ, Freedman R (1979) Modulatory actions of norepinephrine in the central nervous system. Fed Proc 38: 2109–2116

    Google Scholar 

  • Wyatt RJ (1986) The dopamine hypothesis: variations on a theme (II). Psychopharmacol Bull 22: 923–927

    Google Scholar 

  • Yim CY, Mogenson GJ (1982) Response of nucleus accumbens neurons to amygdala stimulation and its modification by dopamine. Brain Res 239: 401

    Google Scholar 

  • Zetterström T, Sharp T, Ungerstedt U (1984) Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis. Eur J Pharmacol 106: 27–37

    Google Scholar 

  • Zigmond MJ, Berger TW, Grace AA, Stricker EM (1989) Compensatory responses to nigrostriatal bundle injury: studies with 6-hydroxydopamine in an animal model of Parkinsonism. Mol Chem Neuropathol 10: 185–200

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grace, A.A. Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia. J. Neural Transmission 91, 111–134 (1993). https://doi.org/10.1007/BF01245228

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01245228

Keywords

Navigation